Specification of 14-3-3 proteins in Lewy bodies [1]

Annals of Neurology

Volumn 54, Issue 1, 2003, Pages 135-

  Berg, Daniela ^a   Riess, Olaf ^a   Bornemann, Antje ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; PROTEIN 14 3 3;

ADULT; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LEWY BODY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA;

EID: 0038462211     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10621     Document Type: Letter

References (5)

1. Ubl A, Berg D, Holzmann C, et al. 14-3-3 protein is a component of Lewy bodies in Parkinson's disease: mutation analysis and association studies of 14-3-3 η. Mol Brain Res 2002;108:33-39.
2. Kawamato Y, Akiguchi I, Nakamura S, et al. 14-3-3 proteins in Lewy bodies in Parkinson's disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 2002;61:245-253.
3. Kawamato Y, Akiguchi I, Nakamura S, Budka H. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 2003;52:722-731.
4. Baxter HC, Liu WG, Forster JL, et al. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 2002;109:5-14.
5. Xu J, Kao SY, Lee FSJ, et al. Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 2002;8:600-606.